InSysBio to participate in SITC 2021

events
Conference
September 23, 2021

September 23, 2021

InSysBio announces its participation in SITC’s 36th Annual Meeting & Pre-Conference Programs (the Society for Immunotherapy of Cancer) which to be held November 10th to 14th, 2021 in person in Washington, DC, and virtually. InSysBio expert modeler Oleg Demin Jr and his student Elena Vasileva are going to present a poster:

Poster Hall

11/12/2021 - 11/14/2021, 7:00 am - 5:00 pm

  • 273 “Application of pharmacokinetic-pharmacodynamic modeling to select the optimal dose of ALX148, a CD47 blocker.” by Elena Vasileva, Oleg Demin Jr

Oleg Demin Jr comments on the poster, “This poster presents part of the work done in the framework of the master thesis. She defended her master thesis and graduated from Lomonosov Moscow State University (MSU) a few months ago. Her PK/PD model describes ALX148 (evorpacept), a CD47 blocker developed by ALX Oncology, and was used to select the RP2D. Very nice work! It is always great to be involved in the training of students by InSysBio”.

Follow our presenters!

About InSysBio

InSysBio is a Quantitative Systems Pharmacology (QSP) company located in Moscow, Russia (INSYSBIO LLC) and Edinburgh, UK (INSYSBIO UK LIMITED). InSysBio was founded in 2004 and has an extensive track record of helping pharmaceutical companies to make right decisions on the critical stages of drug research and development by application of QSP modeling. InSysBio’s innovative QSP approach has already become a part of the drug development process implemented by our strategic partners: there are more than 100 completed projects in collaboration with leaders of pharmaceutical industry. For more information about InSysBio, its solutions and services, visit www.insysbio.com.

March 2017
MoTuWeThFrSaSu
  
1
2
3
4
5
6
7
8
9
1. 09 Mar 2017 14:10 ISBM Enclosed Conference was held 20-22 February 2017 the 10th ISBM Enclosed Conference was held. For ten years the employees annually have been meeting together to share their scientific results and talk over future plans. ISBM did a great job in this working year.
10
11
12
13
14
15
1. 15 Mar 2017 11:49 Institute for Systems Biology participates in American Society for Clinical Pharmacology and Therapeutics 2017 Meeting Institute for Systems Biology Moscow – a company, providing modeling services for innovative drug design, announced participation in ASCPT 2017 Meeting, which is held on 15-18 March in Washington, DC. ISBM will present several studies and demonstrate an updated version of platform for quantitative systems pharmacology modeling of immune response - Immune Response Template (IRT).
16
17
18
19
20
21
22
23
24
25
26
27
28
1. 28 Mar 2017 17:56 Not all therapies are effective: Institute for Systems Biology Moscow to present the results of the Alzheimer’s disease Systems Pharmacology Modeling Moscow, Russia – March 28, 2017. On the 1st April, Tatyana Karelina, ISBM leading specialist in neurodegenerative field, will present a poster entitled "Amyloid toxicity and different mechanisms of action for amyloid-targeted treatments studied by quantitative systems pharmacology model" at the 13th International Conference on Alzheimer's and Parkinson's Diseases and Related Neurological Disorders to be held on March 29 - April 2, Vienna, Austria.
29
30
31
  
Upcoming Events
Tags
Latest News
05.12
InSysBio to celebrate its 20-year anniversary
10.09
InSysBio team to publish the new article in PSPJournal
04.09
InSysBio to launch Immune Response Template version 3.6.3 for QSP modeling
22.02
14th InSysBio’s Annual Internal Scientific Meeting
24.01
InSysBio to present the new Plugin for Sublime Text and Heta compiler Online